Statistics

Total Visits

Views
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a) 960

Total Visits per Month

July 2024 August 2024 September 2024 October 2024 November 2024 December 2024 January 2025
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a) 0 0 0 0 0 12 2

File Downloads

Views
PCSK9InhibitionBarrett2020JournalArticle.pdf 2

Top Country Views

Views
Australia 906
United States 28
Sweden 12
China 6
Argentina 2
Germany 2
Ireland 2
India 2

Top City Views

Views
Armidale 516
Melbourne 182
Mountain View 10
San Mateo 10
Rhodes 6
Shanghai 4
Sydney 4
Andover 2
Bangalore 2
Berowra 2